Terlipressin for Refractory Septic Shock

Clinical trial NCT04339868 · UNKNOWN

Trial details

NCT number: NCT04339868
Sponsor: Mahidol University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Septic Shock Refractory Shock Norepinephrine Adverse Reaction

Start date: 2020-04-03
Primary completion: 2025-03-31
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.